Post-approval studies (Phase 4)UnknownNCT05119426What this trial is testingEffectiveness of a Typhoid Conjugate Vaccine in DRCWho this might be right forTyphoid Fever International Vaccine Institute 48,000
Not applicableStudy completedNCT00573235What this trial is testingEpidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia ColiWho this might be right forEnterobacteriaceae Infections University of Pittsburgh 300
Not applicableStudy completedNCT01766830What this trial is testingRapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)Who this might be right forVisceral LeishmaniasisHuman African TrypanosomiasisEnteric Fever+9 more University Hospital, Geneva 1,927
Large-scale testing (Phase 3)Looking for participantsNCT05035342What this trial is testingFecal Transplantation to Eradicate Colonizing Emergent SuperbugsWho this might be right forEnterobacteriaceae InfectionsFecal Microbiota Transplantation Assistance Publique - Hôpitaux de Paris 214
Early research (Phase 1)Study completedNCT01382095What this trial is testingSafety Study of Recombinant Vaccine to Prevent ETEC DiarrheaWho this might be right forEscherichia Coli Infection U.S. Army Medical Research and Development Command 40
Not applicableStudy completedNCT04146922What this trial is testingSwitch to Oral Antibiotics in Gram-negative BacteremiaWho this might be right forEscherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter Bacteraemia+3 more Hamad Medical Corporation 176
Not applicableStudy completedNCT06419296What this trial is testingMortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.Who this might be right forBacteremia Hospital Italiano de Buenos Aires 265
Testing effectiveness (Phase 2)Ended earlyNCT03354754What this trial is testingLYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)Who this might be right forIntra-abdominal Infections Novartis Pharmaceuticals 3
Not applicableStudy completedNCT03860415What this trial is testingCan Probiotic Vivomixx Eradicate Colonization With ESBL?Who this might be right forAntibiotic Resistant Infection Lund University 80
Not applicableStudy completedNCT00386789What this trial is testingLong Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of AgeWho this might be right forTyphoid Fever Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableStudy completedNCT04117113What this trial is testingStudy to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)Who this might be right forE. Coli Infection UMC Utrecht 238
Not applicableUnknownNCT03778125What this trial is testingMultidrug Resistant Shigella Infection in BangladeshWho this might be right forDiarrheaShigella University of Virginia 2,000
Large-scale testing (Phase 3)Study completedNCT02400268What this trial is testingAntibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by EnterobacteriaceaeWho this might be right forEnterobacteriaceae InfectionsBloodstream Infection Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 238
Testing effectiveness (Phase 2)Looking for participantsNCT05835206What this trial is testingFurther MT for Antibiotic-Resistant Bacterial ColonizationWho this might be right forIntestinal Multi-drug Resistant Organism Colonization Emory University 40
Large-scale testing (Phase 3)Study completedNCT00368316What this trial is testingSafety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in IsraelWho this might be right forShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Testing effectiveness (Phase 2)Study completedNCT04056117What this trial is testingDetermine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan InfantsWho this might be right forShigellosis LimmaTech Biologics AG 597
Early research (Phase 1)Study completedNCT04992520What this trial is testingControlled Human Infection Model Challenge/RechallengeWho this might be right forShigellosis PATH 46
Testing effectiveness (Phase 2)WithdrawnNCT03038243What this trial is testingSafety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in AdultsWho this might be right forShigella Sonnei Dysenteries PATH
Early research (Phase 1)Study completedNCT01369927What this trial is testingShigella Sonnel O-SPC/rBRU Conjugate VaccineWho this might be right forImmunogenicityShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60
Not applicableStudy completedNCT04671290What this trial is testingTemocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing EnterobacteriaceaeWho this might be right forUrinary Tract Infection Bacterial Centre Hospitalier Annecy Genevois 144